Viking Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update
/PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies...
Laguna Niguel Exchange Commission Prnewswire Viking Therapeutics Inc Therapeutics Inc Ligand Pharmaceuticals Incorporated Obesity Society
Source: prnewswire.com